Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90

Angela M. Feraco, Yiwang Zhou, Ying Zheng, Lianna J. Marks, Alison Friedmann, Howard J. Weinstein, Michael P. Link, Jamie E. Flerlage

Blood Adv (2023) 7 (21): 6665–6667.

https://doi.org/10.1182/bloodadvances.2023010944

Published: 2023

Journal Articles

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH

Eline A. M. Zijtregtop, Jamie Zeal, Monika L. Metzger, Kara M. Kelly, Christine Mauz-Koerholz, Stephan D. Voss, Kathleen McCarten, Jamie E. Flerlage, Auke Beishuizen

Blood Adv (2023) 7 (20): 6303–6319.

https://doi.org/10.1182/bloodadvances.2023010024

Published: 2023

Journal Articles

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Christopher J. Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J. Deyell, Jamie E. Flerlage, Anna K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E. Norris, Martha Pacheco, Faye Willen, Adam Paul Yan, Paul D. Harker-Murray, Lisa Giulino-Roth

Blood Adv (2023) 7 (13): 3225–3231.

https://doi.org/10.1182/bloodadvances.2022009323

Published: 2023

Includes: Supplemental data